FilingSEC EDGAR8-K
Vivos Therapeutics Changes Independent Auditor
· SEC accepted
StageAuditor Change
Filing content
Vivos Therapeutics announced the dismissal of Baker Tilly and the appointment of Haynie & Company as its new independent auditor, effective September 29, 2026.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…